The Global Smart Insulin Pens Market was valued USD 102.86 Million in 2022 and is anticipated to reach a value of USD 251.06 Million by 2030. In the projection period, the Global Market is forecasted ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.